← Leaderboards
Naomi Yu Ko
Massachusetts General Hospital
$1,392,762
Attributed
$2,785,523
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $784.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,785,523 · 1
By mechanism
R01$2,785,523 · 1
Top collaborators
- Leif W Ellisen4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Joel S Finkelstein$18,947,740
- Jose M Teixeira$9,923,155
- Simon N Powell$16,981,652
- Schahram Akbarian$48,610,378
- Janet E Hall$12,273,914
Others in their field
Other Rising Stars on “Disease Progression”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Angee Greer · Ppd Development Lp$82,531,927
- Mari Ostendorf · University Of Washington$51,931,230
- Sabrina Paganoni · Massachusetts General Hospital$25,017,559
- Suma Babu · Massachusetts General Hospital$25,017,559
- Dorota A. Grejner-Brzezinska · University Of Wisconsin-Madison$19,883,568
Research focus
Disease ProgressionAfrican AmericanConsensusCollaborationsAggressive Breast CancerAreaAfrican American PopulationBiological MarkersAccountingBostonBreast Cancer PatientCancer BiologyCancer CellCancer Health DisparityBiologicalCellsCharacteristicsChemoresistanceBiologyClinical CareClinical TranslationCohortCohort AnalysisDriver Mutation
Grant awards (4)
Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans$784,127
R01 · FY2025 · CA
Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans$547,398
R01 · FY2024 · CA
Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans$702,828
R01 · FY2023 · CA
Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans$751,170
R01 · FY2022 · CA